Journal
MOLECULAR PHARMACEUTICS
Volume 16, Issue 3, Pages 931-942Publisher
AMER CHEMICAL SOC
DOI: 10.1021/acs.molpharmaceut.8b00827
Keywords
(9R)-9-hydroxystearic acid; keratin; nanoparticles; drug-induced aggregation; histone deacetylases; cell cycle; cell membrane
Funding
- Investigator Grant of the Italian Association for Cancer Research (AIRC) [16740]
- ALMA MATER STUDIORUM, University di Bologna
Ask authors/readers for more resources
Histone deacetylases, HDACs, have been demonstrated to play a critical role in epigenetic signaling and were found to be overexpressed in several type of cancers; therefore, they represent valuable targets for anticancer therapy. 9-Hydroxystearic acid has been shown to bind the catalytic site of HDAC1, inducing G0/G1 phase cell cycle arrest and activation of the p21(wAF1) gene, thus promoting cell growth inhibition and differentiation in many cancer cells. Despite the (R) enantiomer of 9-hydroxystearic acid (9R) displaying a promising in vitro growth-inhibitory effect on the HT29 cell line, its scarce water solubility and micromolar activity require novel solutions for improving its efficacy and bioavailability. In this work, we describe the synthesis and in vitro biological profiling of 9R keratin nanoparticles (9R@ker) obtained through an in-water drug-induced aggregation process. The anticancer activity of 9R@ker was investigated in the HT29 cell line; the results indicate an increased fluidity of cell membrane and a higher intracellular ROS formation, resulting in an unexpected S phase cell cycle arrest (25% increase as compared to the control) induced by 9R@ker with respect to free 9R and an induction of cell death.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available